These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 25542535)

  • 1. In situ DOX-calcium phosphate mineralized CPT-amphiphilic gelatin nanoparticle for intracellular controlled sequential release of multiple drugs.
    Li WM; Su CW; Chen YW; Chen SY
    Acta Biomater; 2015 Mar; 15():191-9. PubMed ID: 25542535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amifostine-conjugated pH-sensitive calcium phosphate-covered magnetic-amphiphilic gelatin nanoparticles for controlled intracellular dual drug release for dual-targeting in HER-2-overexpressing breast cancer.
    Li WM; Chiang CS; Huang WC; Su CW; Chiang MY; Chen JY; Chen SY
    J Control Release; 2015 Dec; 220(Pt A):107-118. PubMed ID: 26478017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ doxorubicin-CaP shell formation on amphiphilic gelatin-iron oxide core as a multifunctional drug delivery system with improved cytocompatibility, pH-responsive drug release and MR imaging.
    Li WM; Chen SY; Liu DM
    Acta Biomater; 2013 Feb; 9(2):5360-8. PubMed ID: 23022876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
    Kashyap S; Singh N; Surnar B; Jayakannan M
    Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
    Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery.
    Tam YT; To KK; Chow AH
    Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
    Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
    ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facile preparation of pH-sensitive micelles self-assembled from amphiphilic chondroitin sulfate-histamine conjugate for triggered intracellular drug release.
    Yu C; Gao C; Lü S; Chen C; Yang J; Di X; Liu M
    Colloids Surf B Biointerfaces; 2014 Mar; 115():331-9. PubMed ID: 24398081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphiphilic polymer-mediated formation of laponite-based nanohybrids with robust stability and pH sensitivity for anticancer drug delivery.
    Wang G; Maciel D; Wu Y; Rodrigues J; Shi X; Yuan Y; Liu C; Tomás H; Li Y
    ACS Appl Mater Interfaces; 2014 Oct; 6(19):16687-95. PubMed ID: 25167168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of l-Tyrosine-Based Enzyme-Responsive Amphiphilic Poly(ester-urethane) Nanocarriers for Multiple Drug Delivery to Cancer Cells.
    Aluri R; Jayakannan M
    Biomacromolecules; 2017 Jan; 18(1):189-200. PubMed ID: 28064504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles.
    Min KH; Lee HJ; Kim K; Kwon IC; Jeong SY; Lee SC
    Biomaterials; 2012 Aug; 33(23):5788-97. PubMed ID: 22591612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
    Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Codelivery of doxorubicin and camptothecin by dual-responsive unimolecular micelle-based β-cyclodextrin for enhanced chemotherapy.
    Gao YE; Bai S; Ma X; Zhang X; Hou M; Shi X; Huang X; Chen J; Wen F; Xue P; Kang Y; Xu Z
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110428. PubMed ID: 31415956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance.
    He Q; Gao Y; Zhang L; Zhang Z; Gao F; Ji X; Li Y; Shi J
    Biomaterials; 2011 Oct; 32(30):7711-20. PubMed ID: 21816467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time visualization of pH-responsive PLGA hollow particles containing a gas-generating agent targeted for acidic organelles for overcoming multi-drug resistance.
    Ke CJ; Chiang WL; Liao ZX; Chen HL; Lai PS; Sun JS; Sung HW
    Biomaterials; 2013 Jan; 34(1):1-10. PubMed ID: 23044041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A robust pH-sensitive drug carrier: aqueous micelles mineralized by calcium phosphate based on chitosan.
    Lv Y; Huang H; Yang B; Liu H; Li Y; Wang J
    Carbohydr Polym; 2014 Oct; 111():101-7. PubMed ID: 25037334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione-triggered dual release of doxorubicin and camptothecin for highly efficient synergistic anticancer therapy.
    Li Y; Yang H; Yao J; Yu H; Chen X; Zhang P; Xiao C
    Colloids Surf B Biointerfaces; 2018 Sep; 169():273-279. PubMed ID: 29787951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
    Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
    Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphiphilic polyelectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperative pH-sensitivity for controlled doxorubicin delivery.
    Huang P; Wang W; Zhou J; Zhao F; Zhang Y; Liu J; Liu J; Dong A; Kong D; Zhang J
    ACS Appl Mater Interfaces; 2015 Mar; 7(11):6340-50. PubMed ID: 25746122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells.
    Wang H; Agarwal P; Zhao S; Xu RX; Yu J; Lu X; He X
    Biomaterials; 2015 Dec; 72():74-89. PubMed ID: 26344365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.